Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrafton Group Regulatory News (GFTU)

Share Price Information for Grafton Group (GFTU)

Share Price is delayed by 15 minutes
Get Live Data
827.60    -0.30 (-0.04%)
Bid:
831.00
Ask:
832.90
Spread: 1.90 (0.229%)
Market Cap: -
GFTU Live PriceLast checked at - London Stock Exchange

Intraday Grafton Group Share Chart

AGM Update

27 Aug 2021 13:00

RNS Number : 0510K
Grafton Group PLC
27 August 2021
 

 

Grafton Group plc

AGM Update

 

Grafton Group plc ("Grafton" or "the Company") announced on 28 April 2021 that while all resolutions put to shareholders at the 2021 Annual General Meeting ("AGM") of the Company were passed, a minority of shareholders chose not to support resolution 3a which related to the re-election of the Company's Non-Executive Chair, Michael Roney.

 

In line with the provisions of the 2018 UK Corporate Governance Code, the Company has reached out to shareholders in order to gain an understanding of the reasons behind their votes and now provides this update on the outcome of the consultation process.

 

On the basis of the views expressed by shareholders who responded, the level of votes against Mr. Roney's re-election was influenced by only two of the Board's seven Directors being female and several shareholders expressed a concern relating to the number of Board appointments held by Mr. Roney in listed companies.

 

As noted in the 2020 Annual Report, the Board's objective is to increase Board diversity and it has initiated a process to appoint an additional female Non-Executive Director which will increase female representation on the Board to more than one-third.

 

The Board appreciates the increased focus on Directors Board commitments and notes that a number of institutional investors have developed specific guidelines and applied a more stringent voting policy in relation to Directors' Board commitments. The Board of Grafton believes that Mr. Roney has always devoted sufficient time to his role as Chair and is confident that he effectively discharges his role. He brings significant international business experience to the role, provides clear direction and leadership of the Board and makes a major contribution to the strategic development of Grafton. The Board is strongly supportive of the role and guidance that Mr. Roney provides to the Company for the benefit of all stakeholders.

The Nomination Committee continues to monitor all Directors' external commitments and would take appropriate action in the event of any concerns being raised about their ability to dedicate sufficient time to their roles as Directors of the Company.

The Company will set out further details on these matters in the 2021 Annual Report.

 

For further information please contact:

Grafton Group plc +353 1 216 0600

Gavin Slark Chief Executive Officer

David Arnold Chief Financial Officer

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPUBGRUPGGGM
Date   Source Headline
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:28 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20263:00 pmRNSNotice of AGM
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSAgreement to Acquire Mercaluz in Spain
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:02 amRNSShare Buyback Programme
5th Mar 20267:00 amRNS2025 Annual Report
5th Mar 20267:00 amRNSFinal Results
27th Feb 20261:00 pmRNSTotal Voting Rights
30th Jan 20264:00 pmRNSTotal Voting Rights
13th Jan 20267:00 amRNSTrading Update
9th Jan 20264:00 pmRNSHolding(s) in Company
9th Jan 202612:00 pmRNSBlock listing Interim Review
2nd Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
3rd Dec 20257:00 amRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSTotal Voting Rights
13th Nov 20257:00 amRNSTrading Update
7th Nov 20255:00 pmRNSCompletion of Seventh Share Buyback Programme
7th Nov 20255:00 pmRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares*
31st Oct 20255:00 pmRNSTotal Voting Rights
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.